IGFBP6 showed its ability to bind the EGR1 promoter and induce its activity in stably transfected nasopharyngeal cancer (NPC) cell lines overexpressing IGFBP6 (Kuo et al., 2010). This evidence concerns the gene EGR1 and nasopharyngeal carcinoma.